Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016199096> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2016199096 endingPage "94" @default.
- W2016199096 startingPage "89" @default.
- W2016199096 abstract "In a phase I trial 34 patients with pancreatic cancer were treated with the murine monoclonal antibody (MAb) BW 494 (BI 51.011) directed against a glycoprotein antigen. The patients received repeated doses of MAb over a time period from 5 to 14 days (highest single dose 100 mg, highest cumulative dose 490 mg). During this treatment serum levels of murine lgG increased to 43.4 μg/ml. The serum half life of murine lgG ranged from 2 to 3 days. Repeated injections of MAb BW 494 were normally well-tolerated when given within the first 15 days. Two patients presented with fatigue and a neuritis-like syndrome 2 weeks after the last lgG infusion which had resolved spontaneously by the next day. Severe allergic reactions were observed in 3 patients after repeated injections of the MAb. These 3 patients had high levels of human anti-murine antibodies (HAMA). Four weeks after the first application of MAb BW 494, 17/18 patients presented with HAMA (lgG). It could be demonstrated that the anti-murine response was in part anti-idiotypic. At the moment 16/34 patients are eligible for evaluation of tumor response. There was no complete or partial remission; however, 2 patients responded with minor tumor regression up to 32 weeks documented by reduction of liver metastases and primary tumor in CAT scan. Five additional patients presented with a long period of stable disease after immunotherapy (up to 40 weeks). Nine patients had progressive tumor disease in spite of MAb treatment." @default.
- W2016199096 created "2016-06-24" @default.
- W2016199096 creator A5008948940 @default.
- W2016199096 creator A5010137020 @default.
- W2016199096 creator A5021280768 @default.
- W2016199096 creator A5023836595 @default.
- W2016199096 creator A5036032282 @default.
- W2016199096 creator A5072030741 @default.
- W2016199096 creator A5082416385 @default.
- W2016199096 creator A5085885564 @default.
- W2016199096 date "1988-01-01" @default.
- W2016199096 modified "2023-09-30" @default.
- W2016199096 title "Immunotherapy of pancreatic cancer with monoclonal antibody BW 494" @default.
- W2016199096 cites W1754937767 @default.
- W2016199096 cites W1978482821 @default.
- W2016199096 cites W1991942320 @default.
- W2016199096 cites W2016292927 @default.
- W2016199096 cites W2037727282 @default.
- W2016199096 cites W2047644188 @default.
- W2016199096 cites W2085414514 @default.
- W2016199096 cites W2128087377 @default.
- W2016199096 cites W2319914084 @default.
- W2016199096 cites W2461886324 @default.
- W2016199096 cites W4298013878 @default.
- W2016199096 doi "https://doi.org/10.1002/ijc.2910410721" @default.
- W2016199096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3162451" @default.
- W2016199096 hasPublicationYear "1988" @default.
- W2016199096 type Work @default.
- W2016199096 sameAs 2016199096 @default.
- W2016199096 citedByCount "15" @default.
- W2016199096 countsByYear W20161990962013 @default.
- W2016199096 crossrefType "journal-article" @default.
- W2016199096 hasAuthorship W2016199096A5008948940 @default.
- W2016199096 hasAuthorship W2016199096A5010137020 @default.
- W2016199096 hasAuthorship W2016199096A5021280768 @default.
- W2016199096 hasAuthorship W2016199096A5023836595 @default.
- W2016199096 hasAuthorship W2016199096A5036032282 @default.
- W2016199096 hasAuthorship W2016199096A5072030741 @default.
- W2016199096 hasAuthorship W2016199096A5082416385 @default.
- W2016199096 hasAuthorship W2016199096A5085885564 @default.
- W2016199096 hasConcept C121608353 @default.
- W2016199096 hasConcept C126322002 @default.
- W2016199096 hasConcept C159654299 @default.
- W2016199096 hasConcept C203014093 @default.
- W2016199096 hasConcept C2776694085 @default.
- W2016199096 hasConcept C2776737053 @default.
- W2016199096 hasConcept C2777701055 @default.
- W2016199096 hasConcept C2778764654 @default.
- W2016199096 hasConcept C2778822529 @default.
- W2016199096 hasConcept C2780210213 @default.
- W2016199096 hasConcept C542903549 @default.
- W2016199096 hasConcept C71924100 @default.
- W2016199096 hasConcept C90924648 @default.
- W2016199096 hasConceptScore W2016199096C121608353 @default.
- W2016199096 hasConceptScore W2016199096C126322002 @default.
- W2016199096 hasConceptScore W2016199096C159654299 @default.
- W2016199096 hasConceptScore W2016199096C203014093 @default.
- W2016199096 hasConceptScore W2016199096C2776694085 @default.
- W2016199096 hasConceptScore W2016199096C2776737053 @default.
- W2016199096 hasConceptScore W2016199096C2777701055 @default.
- W2016199096 hasConceptScore W2016199096C2778764654 @default.
- W2016199096 hasConceptScore W2016199096C2778822529 @default.
- W2016199096 hasConceptScore W2016199096C2780210213 @default.
- W2016199096 hasConceptScore W2016199096C542903549 @default.
- W2016199096 hasConceptScore W2016199096C71924100 @default.
- W2016199096 hasConceptScore W2016199096C90924648 @default.
- W2016199096 hasIssue "S2" @default.
- W2016199096 hasLocation W20161990961 @default.
- W2016199096 hasLocation W20161990962 @default.
- W2016199096 hasOpenAccess W2016199096 @default.
- W2016199096 hasPrimaryLocation W20161990961 @default.
- W2016199096 hasRelatedWork W1593726281 @default.
- W2016199096 hasRelatedWork W186177625 @default.
- W2016199096 hasRelatedWork W1968785525 @default.
- W2016199096 hasRelatedWork W2056685208 @default.
- W2016199096 hasRelatedWork W2089851078 @default.
- W2016199096 hasRelatedWork W2139748726 @default.
- W2016199096 hasRelatedWork W2152393478 @default.
- W2016199096 hasRelatedWork W2162346310 @default.
- W2016199096 hasRelatedWork W2560218540 @default.
- W2016199096 hasRelatedWork W4293433886 @default.
- W2016199096 hasVolume "41" @default.
- W2016199096 isParatext "false" @default.
- W2016199096 isRetracted "false" @default.
- W2016199096 magId "2016199096" @default.
- W2016199096 workType "article" @default.